Christopher L. Bacon

926 total citations
20 papers, 567 citations indexed

About

Christopher L. Bacon is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Christopher L. Bacon has authored 20 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Christopher L. Bacon's work include RNA Interference and Gene Delivery (3 papers), Peptidase Inhibition and Analysis (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Christopher L. Bacon is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), Peptidase Inhibition and Analysis (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Christopher L. Bacon collaborates with scholars based in Ireland, Germany and United States. Christopher L. Bacon's co-authors include Ciaran M. Regan, James S. O’Donnell, Helen Fogarty, Liam Townsend, Jamie M. O’Sullivan, Kevin M. Ryan, Paul Browne, Clíona Ní Cheallaigh, Ignacio Martín‐Loeches and Mary Byrne and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Neurochemistry and European Journal of Pharmacology.

In The Last Decade

Christopher L. Bacon

20 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher L. Bacon Ireland 12 249 169 128 117 70 20 567
Jinrong Liu China 18 121 0.5× 149 0.9× 17 0.1× 65 0.6× 34 0.5× 64 873
Laszlo Groh Netherlands 14 130 0.5× 218 1.3× 48 0.4× 30 0.3× 10 0.1× 32 807
Mihály Balogh Hungary 18 43 0.2× 180 1.1× 22 0.2× 101 0.9× 10 0.1× 45 1.3k
Tejaswi Kandula Australia 8 61 0.2× 92 0.5× 89 0.7× 147 1.3× 91 1.3× 21 438
Nathan Starr United States 5 183 0.7× 92 0.5× 226 1.8× 24 0.2× 5 0.1× 7 448
Simon Cronin United States 12 73 0.3× 55 0.3× 10 0.1× 97 0.8× 35 0.5× 23 500
Stefania Cheli Italy 12 43 0.2× 181 1.1× 6 0.0× 105 0.9× 55 0.8× 37 437
Xiaoyan Ding China 12 165 0.7× 98 0.6× 86 0.7× 27 0.2× 73 1.0× 33 459
Menno Verhave United States 15 15 0.1× 237 1.4× 17 0.1× 47 0.4× 39 0.6× 27 845
Arnoldo Aquino‐Gálvez Mexico 13 59 0.2× 154 0.9× 28 0.2× 41 0.4× 21 0.3× 46 511

Countries citing papers authored by Christopher L. Bacon

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Bacon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Bacon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Bacon more than expected).

Fields of papers citing papers by Christopher L. Bacon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Bacon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Bacon. The network helps show where Christopher L. Bacon may publish in the future.

Co-authorship network of co-authors of Christopher L. Bacon

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Bacon. A scholar is included among the top collaborators of Christopher L. Bacon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Bacon. Christopher L. Bacon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bacon, Christopher L., et al.. (2024). Chimeric Antigen Receptor‐T (CAR‐T) Cells as “Living Drugs”: A Clinical Pharmacist Perspective. Journal of Clinical Pharmacy and Therapeutics. 2024(1). 1 indexed citations
2.
Smyth, Elizabeth, et al.. (2022). Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals. European Journal Of Haematology. 109(5). 441–446. 1 indexed citations
3.
Fogarty, Helen, David O’Brien, Christopher L. Bacon, et al.. (2020). Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemias. Irish Journal of Medical Science (1971 -). 190(3). 1087–1094. 2 indexed citations
4.
Fogarty, Helen, Liam Townsend, Clíona Ní Cheallaigh, et al.. (2020). COVID19 coagulopathy in Caucasian patients. British Journal of Haematology. 189(6). 1044–1049. 276 indexed citations
5.
Langabeer, Stephen E., Karl Haslam, David O’Brien, et al.. (2016). Acute Lymphoblastic Leukemia Arising inCALRMutated Essential Thrombocythemia. SHILAP Revista de lepidopterología. 2016. 1–5. 4 indexed citations
6.
Leahy, Timothy Ronan, Owen Smith, Christopher L. Bacon, et al.. (2013). Does vaccine dose predict response to the monovalent pandemic H1N1 influenza a vaccine in children with acute lymphoblastic leukemia? A single‐centre study. Pediatric Blood & Cancer. 60(10). 1656–1661. 8 indexed citations
7.
8.
Curry, Sarah, Christopher L. Bacon, Ian Robinson, Michael Capra, & Owen Smith. (2010). Leukaemic alveolar rhabdomyosarcoma. British Journal of Haematology. 151(3). 208–208. 2 indexed citations
9.
Gallagher, Helen C., et al.. (2003). Valproate activates phosphodiesterase-mediated cAMP degradation: relevance to C6 glioma G1 phase progression. Neurotoxicology and Teratology. 26(1). 73–81. 17 indexed citations
10.
Bacon, Christopher L., Helen C. Gallagher, John C. Haughey, & Ciaran M. Regan. (2002). Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase. Journal of Neurochemistry. 83(1). 12–19. 38 indexed citations
11.
Walmod, Peter S., Helen C. Gallagher, Ute Gravemann, et al.. (2002). Automated in Vitro Screening of Teratogens. Toxicology and Applied Pharmacology. 181(1). 1–15. 20 indexed citations
12.
Bacon, Christopher L., et al.. (2000). Antiproliferative actions of inhalational anesthetics: comparisons to the valproate teratogen. International Journal of Developmental Neuroscience. 18(1). 39–45. 18 indexed citations
13.
Zhao, Shikai, Jeremiah P. Freeman, Christopher L. Bacon, et al.. (1999). Syntheses of 1,2-diamino and 1,2-aminoalcohol derivatives in the piperidine and pyrrolidine series as anti-amnesic agents. Bioorganic & Medicinal Chemistry. 7(8). 1647–1654. 3 indexed citations
14.
Zhao, Shikai, Michael J. Totleben, Jeremiah P. Freeman, et al.. (1999). Syntheses of benzoquinolizidine and benzoindolizidine derivatives as anti-amnesic agents. Bioorganic & Medicinal Chemistry. 7(8). 1637–1646. 11 indexed citations
15.
16.
Ehlers, Katharine, Christopher L. Bacon, Anna Kawa, et al.. (1998). Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre. European Journal of Pharmacology. 354(2-3). 289–299. 53 indexed citations
17.
Bacon, Christopher L., et al.. (1997). Correlation of in vitro anti‐proliferative potential with in vivo teratogenicity in a series of valproate analogues. International Journal of Developmental Neuroscience. 15(1). 37–43. 26 indexed citations
18.
Bacon, Christopher L., et al.. (1997). Valproic acid suppresses G1 phase‐dependent sialylation of a 65 kDa glycoprotein in the C6glioma cell cycle. International Journal of Developmental Neuroscience. 15(6). 777–784. 13 indexed citations
19.
Bacon, Christopher L., et al.. (1994). Purification and characterisation of an aminopeptidase A from cytoplasm of Lactococcus lactis subsp. cremoris AM2. International Dairy Journal. 4(6). 503–519. 13 indexed citations
20.
Bacon, Christopher L., et al.. (1993). Purification and characterisation of an aminotripeptidase from cytoplasm of Lactococcus lactis subsp. cremoris AM2. International Dairy Journal. 3(2). 163–177. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinrong Liu Breakdown of academic impact, for papers by Laszlo Groh Breakdown of academic impact, for papers by Mihály Balogh Breakdown of academic impact, for papers by Tejaswi Kandula Breakdown of academic impact, for papers by Nathan Starr Breakdown of academic impact, for papers by Simon Cronin Breakdown of academic impact, for papers by Stefania Cheli Breakdown of academic impact, for papers by Xiaoyan Ding Breakdown of academic impact, for papers by Menno Verhave Breakdown of academic impact, for papers by Arnoldo Aquino‐Gálvez
Rankless by CCL
2026